Oxidised high-density lipoprotein in sarcopenia: a pilot study
- PMID: 35846413
- PMCID: PMC9278172
- DOI: 10.5114/amsad.2022.116664
Oxidised high-density lipoprotein in sarcopenia: a pilot study
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Recombinant Domain V of beta (2)-Glycoprotein I Inhibits OxLDL-induced TF Expression in Macrophages.J Pak Med Assoc. 2018 Nov;68(11):1644-11649. J Pak Med Assoc. 2018. PMID: 30410143
-
High-quality fish oil has a more favourable effect than oxidised fish oil on intermediate-density lipoprotein and LDL subclasses: a randomised controlled trial.Br J Nutr. 2017 May;117(9):1291-1298. doi: 10.1017/S0007114517001167. Epub 2017 May 31. Br J Nutr. 2017. PMID: 28558855 Clinical Trial.
-
High density lipoprotein efficiently accepts surface but not internal oxidised lipids from oxidised low density lipoprotein.Biochim Biophys Acta. 2016 Feb;1861(2):69-77. doi: 10.1016/j.bbalip.2015.11.002. Epub 2015 Nov 10. Biochim Biophys Acta. 2016. PMID: 26569052
-
Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.Pharmacol Ther. 1997;74(1):55-72. doi: 10.1016/s0163-7258(96)00202-1. Pharmacol Ther. 1997. PMID: 9336016 Review.
-
Antibodies to oxidised LDL.Lupus. 2000;9(3):202-5. doi: 10.1191/096120300678828280. Lupus. 2000. PMID: 10805488 Review.
Cited by
-
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia in individuals with cancer: a cross-sectional study.Lipids Health Dis. 2024 Jul 16;23(1):217. doi: 10.1186/s12944-024-02205-x. Lipids Health Dis. 2024. PMID: 39014376 Free PMC article.
References
-
- Tournadre A, Vial G, Capel F, et al. . Sarcopenia. Joint Bone Spine 2019; 86: 309-14. - PubMed
-
- Chen LK, Woo J, Assantachai P, et al. . Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020; 21: 300-7, e2. - PubMed
-
- Lippi G, Sanchis-Gomar F, Montagnana M. Biological markers in older people at risk of mobility limitations. Curr Pharm Des 2014; 20: 3222-44. - PubMed
-
- Rossi P, Marzani B, Giardina S, et al. . Human skeletal muscle aging and the oxidative system: cellular events. Curr Aging Sci 2008; 1: 182-91. - PubMed
-
- Cesari M, Kritchevsky SB, Nicklas BJ, et al. . Lipoprotein peroxidation and mobility limitation: results from the Health, Aging, and Body Composition Study. Arch Intern Med 2005; 165: 2148-54. - PubMed
LinkOut - more resources
Full Text Sources